ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)
- Resource Type
- Review Article
- Source
- In
Clinical Microbiology and Infection June 2018 24 Supplement 2:S71-S82 - Subject
- Language
- ISSN
- 1198-743X